173 related articles for article (PubMed ID: 36187114)
1. MIEAP and ATG5 are tumor suppressors in a mouse model of BRAF
Hamada K; Kurashige T; Shimamura M; Arakawa H; Nakamura Y; Nagayama Y
Front Endocrinol (Lausanne); 2022; 13():932754. PubMed ID: 36187114
[TBL] [Abstract][Full Text] [Related]
2. Causative role for defective expression of mitochondria-eating protein in accumulation of mitochondria in thyroid oncocytic cell tumors.
Mussazhanova Z; Shimamura M; Kurashige T; Ito M; Nakashima M; Nagayama Y
Cancer Sci; 2020 Aug; 111(8):2814-2823. PubMed ID: 32458504
[TBL] [Abstract][Full Text] [Related]
3. Acceleration of BRAF
Shimamura M; Kurashige T; Kuatov R; Nakashima M; Nagayama Y
Endocrine; 2020 Sep; 69(3):571-577. PubMed ID: 32281047
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Mieap-regulated mitochondrial quality control as a new function of tumor suppressor p53.
Nakamura Y; Arakawa H
Cancer Sci; 2017 May; 108(5):809-817. PubMed ID: 28222492
[TBL] [Abstract][Full Text] [Related]
5. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW
World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration.
Ferreira-da-Silva A; Valacca C; Rios E; Pópulo H; Soares P; Sobrinho-Simões M; Scorrano L; Máximo V; Campello S
PLoS One; 2015; 10(3):e0122308. PubMed ID: 25822260
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone (T
Yau WW; Singh BK; Lesmana R; Zhou J; Sinha RA; Wong KA; Wu Y; Bay BH; Sugii S; Sun L; Yen PM
Autophagy; 2019 Jan; 15(1):131-150. PubMed ID: 30209975
[TBL] [Abstract][Full Text] [Related]
8. Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism.
Strohecker AM; White E
Autophagy; 2014 Feb; 10(2):384-5. PubMed ID: 24362353
[TBL] [Abstract][Full Text] [Related]
9.
Kim M; Kim SJ; Xu Z; Ha SY; Byeon JH; Kang EJ; Shin SH; Yoo SK; Jee HG; Yoon SG; Yi JW; Bae JM; Yu HW; Chai YJ; Cho SW; Choi JY; Lee KE; Han W
Thyroid; 2020 Apr; 30(4):487-500. PubMed ID: 32122255
[No Abstract] [Full Text] [Related]
10. Postnatal expression of BRAFV600E does not induce thyroid cancer in mouse models of thyroid papillary carcinoma.
Shimamura M; Nakahara M; Orim F; Kurashige T; Mitsutake N; Nakashima M; Kondo S; Yamada M; Taguchi R; Kimura S; Nagayama Y
Endocrinology; 2013 Nov; 154(11):4423-30. PubMed ID: 23970782
[TBL] [Abstract][Full Text] [Related]
11. Defective ciliogenesis in thyroid hürthle cell tumors is associated with increased autophagy.
Lee J; Yi S; Kang YE; Chang JY; Kim JT; Sul HJ; Kim JO; Kim JM; Kim J; Porcelli AM; Kim KS; Shong M
Oncotarget; 2016 Nov; 7(48):79117-79130. PubMed ID: 27816963
[TBL] [Abstract][Full Text] [Related]
12. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation.
Wang Z; Zhou H; Zheng H; Zhou X; Shen G; Teng X; Liu X; Zhang J; Wei X; Hu Z; Zeng F; Hu Y; Hu J; Wang X; Chen S; Cheng J; Zhang C; Gui Y; Zou S; Hao Y; Zhao Q; Wu W; Zhou Y; Cui K; Huang N; Wei Y; Li W; Li J
Autophagy; 2021 Feb; 17(2):529-552. PubMed ID: 32019420
[TBL] [Abstract][Full Text] [Related]
13. Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in
Valvo V; Iesato A; Kavanagh TR; Priolo C; Zsengeller Z; Pontecorvi A; Stillman IE; Burke SD; Liu X; Nucera C
Thyroid; 2021 Sep; 31(9):1335-1358. PubMed ID: 33107403
[No Abstract] [Full Text] [Related]
14. Mitochondrial localization and regulation of BRAFV600E in thyroid cancer: a clinically used RAF inhibitor is unable to block the mitochondrial activities of BRAFV600E.
Lee MH; Lee SE; Kim DW; Ryu MJ; Kim SJ; Kim SJ; Kim YK; Park JH; Kweon GR; Kim JM; Lee JU; De Falco V; Jo YS; Shong M
J Clin Endocrinol Metab; 2011 Jan; 96(1):E19-30. PubMed ID: 20926530
[TBL] [Abstract][Full Text] [Related]
15. p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers.
Sano H; Futamura M; Gaowa S; Kamino H; Nakamura Y; Yamaguchi K; Tanaka Y; Yasufuku I; Nakakami A; Arakawa H; Yoshida K
Biochem Biophys Res Commun; 2020 Aug; 529(3):582-589. PubMed ID: 32736677
[TBL] [Abstract][Full Text] [Related]
16.
Jiménez-Mora E; Gallego B; Díaz-Gago S; Lasa M; Baquero P; Chiloeches A
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204950
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial metabolism is inhibited by the HIF1α-MYC-PGC-1β axis in BRAF V600E thyroid cancer.
Gao Y; Yang F; Yang XA; Zhang L; Yu H; Cheng X; Xu S; Pan J; Wang K; Li P
FEBS J; 2019 Apr; 286(7):1420-1436. PubMed ID: 30768848
[TBL] [Abstract][Full Text] [Related]
18. β-Catenin Attenuation Inhibits Tumor Growth and Promotes Differentiation in a BRAF
Zou M; BinEssa HA; Al-Malki YH; Al-Yahya S; Al-Alwan M; Al-Jammaz I; Khabar KSA; Almohanna F; Assiri AM; Meyer BF; Alzahrani AS; Al-Mohanna FA; Shi Y
Mol Cancer Ther; 2021 Sep; 20(9):1603-1613. PubMed ID: 34224366
[No Abstract] [Full Text] [Related]
19. miR-216b enhances the efficacy of vemurafenib by targeting Beclin-1, UVRAG and ATG5 in melanoma.
Luo M; Wu L; Zhang K; Wang H; Wu S; O'Connell D; Gao T; Zhong H; Yang Y
Cell Signal; 2018 Jan; 42():30-43. PubMed ID: 28982601
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin signaling confers more aggressive features with higher genomic instability on BRAF(V600E)-induced thyroid tumors in a mouse model.
Orim F; Bychkov A; Shimamura M; Nakashima M; Ito M; Matsuse M; Kurashige T; Suzuki K; Saenko V; Nagayama Y; Yamashita S; Mitsutake N
Thyroid; 2014 Mar; 24(3):502-10. PubMed ID: 23924149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
